Document Detail


Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
MedLine Citation:
PMID:  3873469     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hormonal measurements and HLA genotyping of amniotic fluid at midgestation correctly predicted the postnatal diagnosis of congenital adrenal hyperplasia (CAH) in 29 of 32 fetuses at risk. Of these 29, 7 were predicted to have prenatal-onset classical 21-hydroxylase deficiency (21-OH def) based on elevated amniotic fluid 17-hydroxyprogesterone (17-OHP) and delta 4-androstenedione (delta 4-A) levels. These 7 fetuses and their index cases were ultimately proven to have salt-wasting classical 21-OH def. Of 5 who were HLA typed, the genotype was identical to the index case in 4; in one, HLA prediction was not possible, because the parents shared identical HLA antigens. Normal amniotic fluid 17-OHP and delta 4-A levels in the remaining 22 fetuses predicted that they were not affected with classical CAH. These children have been clinically asymptomatic to date or proven biochemically not to have classical or nonclassical CAH. Of the 22 fetuses, 11 were predicted by HLA genotyping to be homozygous normal or heterozygous for 21-OH def. In 3 of the 32 fetuses, prenatal diagnosis was incorrect. In one, the fetus was predicted to have CAH based on HLA identity to the index case. However, amniotic fluid 17-OHP and delta 4-A were normal, and the fetus was normal. The index case of this family did not have CAH, but was a normal child. Thus, amniotic fluid hormone levels accurately predicted a normal fetus, while HLA genotyping was not relevant in prenatal diagnosis because the index case was unaffected. The second fetus was predicted to be affected on the basis of HLA genotyping and to be unaffected based on normal amniotic fluid 17-OHP and delta 4-A. During infancy, this female infant had postnatal-onset nonclassical CAH. The index case in this family, presumed to have classical simple virilizing CAH, was later diagnosed to have nonclassical CAH. Thus, in nonclassical CAH, hormonal measurement of 17-OHP and delta 4-A is not useful in prenatal diagnosis; only HLA genotyping of the fetus is valuable. In the third case, the fetus was predicted to be a heterozygote by HLA genotyping and to be unaffected by hormonal measurement. Postnatally, at age 2 7/12 yr, the male child was found to have classical simple virilizing CAH and to be HLA-B-DR identical to his brother (index case) who also has classical simple virilizing CAH.(ABSTRACT TRUNCATED AT 400 WORDS)
Authors:
S Pang; M S Pollack; M Loo; O Green; R Nussbaum; G Clayton; B Dupont; M I New
Related Documents :
12765319 - The effects of asthma on pregnancy and perinatal outcomes.
1732479 - Amniotic fluid composition responds to changes in maternal dietary carbohydrate and is ...
7639939 - Single-needle insertion: an alternative technique for early second-trimester genetic tw...
2192319 - Amniotic fluid assessment.
14616249 - C-reactive protein in vaginal fluid of patients with preterm premature rupture of membr...
10561649 - Effect of fetal presentation on the amniotic fluid index.
19164479 - Predominance of local over systemic factors in uterine arterial remodeling during pregn...
9109199 - Case studies in wildlife immunocontraception: wild and feral equids and white-tailed deer.
6691379 - Accelerations of the human fetal heart rate at 38 to 40 weeks' gestational age.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  61     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1985 Jul 
Date Detail:
Created Date:  1985-07-23     Completed Date:  1985-07-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  89-97     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
17-alpha-Hydroxyprogesterone
Adrenal Hyperplasia, Congenital* / diagnosis*,  genetics
Amniotic Fluid / metabolism
Androstenedione / metabolism
Female
Genotype
HLA Antigens / genetics
Heterozygote
Homozygote
Humans
Hydroxyprogesterones / metabolism
Male
Pregnancy
Prenatal Diagnosis / methods*
Risk
Steroid Hydroxylases / deficiency*
Grant Support
ID/Acronym/Agency:
AM-33988/AM/NIADDK NIH HHS; CA-37888/CA/NCI NIH HHS; HD-00072/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/HLA Antigens; 0/Hydroxyprogesterones; 63-05-8/Androstenedione; 68-96-2/17-alpha-Hydroxyprogesterone; EC 1.14.-/Steroid Hydroxylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Androgen receptor in cultured human testicular fibroblasts.
Next Document:  Preparation and characterization of antisera and monoclonal antibodies to serotonergic and dopaminer...